RECHEM
Welcome to our website!|Hot Line: 86-21-31433387|E-mail: sales@rechemscience.com
Products Category
Contact Us
| Tel: | +86-21-31433387 |
| +86-15618786686 | |
| Email: | sales@rechemscience.com |
| info@rechemscience.com | |
| QQ: | 1369748377 |
| Skype: | sales@rechemscience.com |
Home > Products
| Cat.No. | Product name | Product Description |
| R11588 | MCB-613 | MCB-613 is a potent Steroid receptor coactivator SRC small molecule ‘s |
| R11589 | Poziotinib(NOV120101; HM781-36B) | Poziotinib(NOV120101; HM781-36B) is an irreversible Pan-HER inhibitor with IC50s |
| R11590 | Fisogatinib;BLU-554 | BLU-554 is a potent fibroblast growth factor receptor 4 (FGFR4) inhibitor. |
| R11591 | GSK-461364; GSK-461364A | GSK461364 inhibits purified Plk1 with Ki of 2.2 nM in a cell-free assay. It is m |
| R11592 | GDC-0326 | GDC-0326 is a potent and selective PI3Kα inhibitor with a Ki |
| R11593 | Batefenterol (GSK961081; TD-5959) | Batefenterol (GSK961081;TD-5959) is a novel muscarinic receptor antago |
| R11594 | GSK-961081;Batefenterol succinate | Batefenterol is a novel muscarinic receptor antagonist and β2-adr |
| R11595 | CCT251545 | CCT251545 is an orally bioavailable and potent inhibitor of WNT signaling with I |
| R11596 | BAR 502 | BAR502 is a dual FXR and GPBAR1 agonist with IC50 |
| R11597 | BAR 501 | N/A |
| R11598 | CCT251921 | CCT-251921 is a potent, selective, and orally bioavailable CDK8 inhibi |
| R11599 | OTS964 hydrochloride | OTS964 hydrochloride is an orally active, high affinity and selective TOPK (T-ly |
| R11600 | Bemcentinib (Synonyms: R428; BGB324) | R428 (BGB324) is an inhibitor of Axl with IC50 of 14 nM, >100-fold selective |
| R11601 | Neratinib Maleate | Neratinib is an orally available, irreversible tyrosine kinase inhibitor with IC |
| R11602 | HM61713 | Olmutinib (HM61713; BI-1482694) is an orally bioavailab and irreversible third&n |
| R11603 | WZ3146 | WZ3146 is a mutant-selective irreversible inhibitor of EGFR(L858R) and |
| R11604 | Edoxaban | Edoxaban(DU-176) is an oral factor Xa (FXa) inhibitor in clinical development fo |
| R11605 | MK-571 sodium salt; L-660711 (sodium salt) | MK-571 is a selective, orally active CysLT1 receptor(Cysteinyl leukotriene recep |
| R11606 | BML-284 | Wnt agonist 1 is a cell permeable Wnt signaling pathway activator, whi |
| R11607 | KM 11060 | KM11060 is a novel corrector of the F508del-CFTR trafficking defect. |
| R11608 | Mirin | Mirin is a potent Mre11–Rad50–Nbs1 (MRN) complex inhibitor, and inhibits Mre11-a |
| R11609 | YM90709 | YM-90709 is a novel antagonist which inhibits the binding of interleukin-5 to in |
| R11610 | SC 66 | SC66 is a novel AKT inhibitor, IC50 values of approximately 0.75 μg/ml at 72 hou |
| R11611 | KENPAULLONE | Kenpaullone is an ATP-competitive inhibitor of cyclin-dependent kinases (CD |
| R11612 | K 858 | K858 selectively inhibits Eg5 ATPase activity with an IC50 of 1.3 μM. |
